NanoViricides is trading at $1.20 (+7.14%) in pre-market on September 8, 2026, with the catalyst unclear.
- No fresh company announcement dated September 7 or September 8 was identified.
- The latest company update, dated August 31, discussed measles cases and preparation for NV-387 clinical trials, without linking the news to a stock-price move.
- Broader markets are mixed to lower.